Vanguard Global Advisers
HURA

Vanguard Global Advisers’s TuHURA Biosciences HURA Stock Holding History

Vanguard Global Advisers’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7K Hold
9,684
– – ﹤0.01% 3295
2026
Q1 		$17.3K Buy
+9,684
New +$11.9K ﹤0.01% 3360

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Global Advisers's HURA Position: Q2 2026 in Review

Vanguard Global Advisers held its TuHURA Biosciences (HURA) position steady in Q2 2026 at 9,684 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3295.

Vanguard Global Advisers first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. 83 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Vanguard Global Advisers held 9,684 shares of TuHURA Biosciences worth $22.7K as of Q2 2026.
  • Vanguard Global Advisers left its TuHURA Biosciences share count unchanged in Q2 2026.
  • TuHURA Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3295 holding.
  • Vanguard Global Advisers first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 83 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.